Just info on holding company[url=https://ceo.ca/@marketwired/first-generation-capital-inc-enters-into-agreement-to-purchase-common-shares-of-acerus-pharmaceuticals-corporation-4b929]https://ceo.ca/@marketwired/first-generation-capital-inc-enters-into-agreement-to-purchase-common-shares-of-acerus-pharmaceuticals-corporation-4b929[/url]
Great peice of infomation about the current holding company which pick up #ASP shares last year.
TORONTO, ONTARIO--(Marketwired - May 13, 2016) - Mr. Ian Ihnatowycz announced that effective May 13, 2016, First Generation Capital Inc. entered into an agreement with West Face Long Term Opportunities Global Master L.P. and K2 Principal Fund L.P. pursuant to which First Generation agreed to purchase (the "Transaction") an aggregate of 51,437,691 common shares of Acerus Pharmaceuticals Corporation ("Acerus") for an aggregate price of $10,246,387.90 or $0.1992 per share.
Immediately prior to the Transaction, First Generation owned 51,081,093 common shares of Acerus, or approximately 23.97% of the outstanding common shares. After closing of the Transaction, First Generation will own 102,518,784 common shares or approximately 48.1% of the outstanding common shares of Acerus.
The Transaction is being conducted privately in accordance with the "private agreement" exemption contained in section 4.2 of National Instrument 62-104.